Frenel DeMorin

Title: The Innovative Contributions of Frenel DeMorin in Kinase Inhibitors

Introduction

Frenel DeMorin, an accomplished inventor based in Long Beach, California, has made significant strides in the pharmaceutical industry. As a member of Exelixis, Inc., he has played a vital role in developing innovative solutions aimed at treating various diseases. His expertise in the field of kinase inhibitors has led to the patenting of a notable invention.

Latest Patents

DeMorin holds a patent for "Crystalline forms and salt forms of a kinase inhibitor." This groundbreaking invention focuses on crystalline forms of the free base of the c-Met inhibitor, known as Compound 1. It also encompasses the crystalline forms of salts related to Compound 1 and highlights the pharmaceutical compositions that include these solid polymorphs. Additionally, the patent outlines methods for treating diseases, disorders, or syndromes that involve modulating the in vivo activity of a protein kinase.

Career Highlights

Working at Exelixis, Inc., Frenel DeMorin has established himself as a pivotal figure within the organization. His groundbreaking work in developing kinase inhibitors has contributed to advances in targeted therapies, particularly for conditions that rely on protein kinase modulation. With one patent to his name, he demonstrates a strong commitment to innovation and research.

Collaborations

Throughout his career, DeMorin has collaborated with talented professionals, including Khalid Ali Shah and Sagar Shakya. These partnerships within Exelixis, Inc. have fostered an environment of creativity and teamwork, enabling the development of effective therapeutic solutions that can address unmet medical needs.

Conclusion

Frenel DeMorin stands out as an innovative inventor in the realm of kinase inhibitors. His patent achievements reflect his dedication to advancing medical science through research and collaboration. As a prominent figure at Exelixis, Inc., he continues to contribute to the field, providing hope for those affected by diseases influenced by protein kinases.